Clinical and Diagnostic Laboratory Immunology, November 1998, p. 808-813, Vol. 5, No. 6
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Evaluation of a Novel Mononuclear Cell Isolation
Procedure for Serological HLA Typing
Peter
Schlenke,1,*
Harald
Klüter,1
Michael
Müller-Steinhardt,1
Hans-Jörg
Hammers,1
Kerstin
Borchert,1 and
Gregor
Bein2
Institute of Immunology and Transfusion
Medicine, University of Luebeck School of Medicine, D23538
Luebeck,1 and
Institute of Clinical
Immunology and Transfusion Medicine, University of Giessen, D35392
Giessen,2 Germany
Received 4 May 1998/Returned for modification 7 June 1998/Accepted 18 September 1998
 |
ABSTRACT |
Despite recent advances in DNA-based genotyping, the
microcytotoxicity test is still broadly used for the determination of human leukocyte class I antigens in patients as well as organ donors
and also for the detection of HLA antibodies. Excellent purity and
viability of peripheral blood mononuclear cells (PBMC) are essential
for reliable HLA typing results. Background staining and cell loss can
contribute to impaired typing results or even cause misinterpretations.
A novel isolation procedure using cell preparation tubes (CPT) with
prefilled Ficoll was compared with the standard Ficoll gradient. We
determined the recovery, purity, and viability of the PBMC after
several periods of storage. Finally, the isolated cells were used for
HLA class I typing, and background reactivities were scored. By using
the CPT method, the recovery of PBMC was significantly higher than
recovery with the standard technique (P
0.001). Contamination by granulocytes increased considerably
during the storage time for the standard protocol, whereas purity
remained stable when CPT were used (P
0.001). With both methods, lymphocyte viability declined markedly over time. We
found significantly more dead cells by using the CPT methods. Due to
high background scores, HLA typing was impossible after 48 h. The
isolation of PBMC by the CPT method resulted in a higher yield and
improved purity compared to those obtained with the standard gradient
technique. The decreasing viability after 48 h limits the use of
both methods for HLA typing and HLA antibody screening.
 |
INTRODUCTION |
Since new technologies based on the
invention of the PCR by Mullis (10) have become available,
serological HLA typing has been partially replaced. Included among
these new technologies is the precise DNA typing of HLA class II
alleles by amplification with sequence-specific oligonucleotides
(14), by sequence-specific priming (2, 11), or by
sequenced-based typing (3); all of these have led to
considerable improvements in organ and bone marrow transplantation.
Nevertheless, the microcytotoxicity test (18) has still
remained the standard for HLA class I typing in patients and organ
donors and for crossmatch techniques. The isolation of peripheral blood
mononuclear cells (PBMC) from blood samples is an important
preanalytical step, not only for HLA typing, but also for other routine
laboratory procedures such as flow cytometry (1, 12, 16,
17). Alternatively, when only erythrocyte depletion is called
for, lysis procedures using ammonium chloride or hypotonic solutions
are frequently used (9, 19); these have the advantage of
bypassing the overall cell loss and the well-known depletion of
specific subpopulations (1, 12, 16, 17) that occur when
density gradients are used. With these methods, depletions of
erythrocytes and granulocytes are accomplished with a relative
enrichment of PBMC, as first described by Böyum (4, 5). Additional lymphocyte enrichment strategies using nylon wool
columns or immunomagnetic beads (21) are also used.
Conventional techniques demand substantial manual skills for blood
layering and interface removal; they are also time-consuming and
sometimes imprecise due to selective cell loss and impure segregation
(1, 12, 16, 17).
The purpose of our study was to compare the Ficoll density gradient
technique with a newly developed method using Ficoll prefilled cell
preparation tubes (CPT). We evaluated the recovery and purity of PBMC
by flow cytometry, which allowed for precise cell quantification by
using fluorochrome-containing microparticles. We further assessed the
viabilities of lymphocytes by propidium iodide staining. Studies to
determine the influence of storage time before or after PBMC isolation
on cell recovery and quality were also performed (6, 8, 13,
22). Subsequently, the isolated cells were subjected to HLA class
I typing. The typing quality was assessed microscopically by using the
score recommended by the International Histocompatibility Workshop (IHW).
 |
MATERIALS AND METHODS |
Samples and study design.
Peripheral blood samples (2.7 ml
of K-EDTA) were obtained from 10 healthy volunteers after informed
consent was given. Leukocyte subsets were quantified immediately after
donation by flow cytometry. Three 8-ml samples were collected from each
donor in tubes containing anticoagulant citrate-dextrose solution,
formula A (ACD-A) (Becton Dickinson Vacutainer Systems, Franklin Lakes,
N.J.) and stored at 20°C for either 2, 24, or 48 h before the
Ficoll gradient procedure was performed. In parallel, five 8-ml samples
were instilled directly into CPT (Becton Dickinson Vacutainer Systems),
which contained 1.0 ml of 0.1 M sodium citrate, 1 ml of Ficoll-Hypaque,
and a gel barrier. Three of these CPT were left at 20°C for either 2, 24, or 48 h, whereas the other two samples were centrifuged
immediately after collection. PBMC were mixed with the plasma
supernatants in the original CPT and stored at 20°C for either 24 or
48 h.
Isolation of PBMC by the standard density gradient
technique.
ACD-A-anticoagulated blood was diluted 1:1 with Hank's
buffer and completely layered on an identical volume of the density gradient (Lymphoflot; Biotest, Dreieich, Germany), which contained 5.6% Ficoll and 9.6% diactrizoate with a density of 1.077 ± 0.001 g/ml and an osmolarity of 300 mosM. Samples were centrifuged for 20 min at 700 × g and 20°C without applying a brake.
The PBMC interface was carefully removed by pipetting and was washed
twice with Hank's buffer by stepwise centrifugation for 15 min at
300 × g and for 10 min at 90 × g for
platelet removal. PBMC were resuspended in 3 ml of Lymphostabil
(Biotest), a Terasaki Park medium which contains several amino acids,
D-glucose, HEPES buffer, and 0.5% fetal calf serum.
Isolation of PBMC by using CPT.
Two CPT were centrifuged
immediately after collection (protocol A) before the PBMC were mixed
with the autologous plasma supernatants. These samples remained
unopened for either 24 or 48 h. Three CPT were first stored at
20°C (protocol B) and then centrifuged after either 2, 24, or 48 h. Centrifugation was performed for 20 min at 1,730 × g and 20°C. At the end of each storage interval, PBMC were
subjected to the washing procedures with Hank's buffer that are
described above.
Flow cytometric cell quantification and viability
determination.
All flow cytometric analyses were performed on an
EPICS XL MCL (Coulter Immunotech, Krefeld, Germany) flow cytometer, and System II software was used for data acquisition. The flow cytometer was properly aligned, and fluorochrome compensation for fluorescein isothiocyanate (FITC) and phycoerythin (PE) was correctly tuned with
respect to signal amplification. All specific monoclonal antibodies,
namely, anti-CD45-FITC (clone DW124-5-2), anti-CD14-PE (clone 116),
anti-CD3-FITC (clone UCHT1), and anti-CD19-FITC (clone 89B), and the
isotype control antibodies (immunoglobulin G1 [IgG1] and IgG2a) were
purchased from Coulter Immunotech. One hundred microliters of the
sample and 20 µl of each antibody were incubated for 20 min at 4°C
in the dark. Erythrocyte lysis was performed automatically by a
Multi-QPrep workstation (Coulter Immunotech). For direct quantitation
of lymphocyte subpopulations (15), 100-µl Flow Count
Fluorospheres (Coulter Immunotech) were added to the prepared
specimens. Cell concentrations were calculated by using the following
formula: number of cells/µl = total number of cells of
interest/total number of Fluorospheres × assayed concentration of
Fluorospheres/µl.
As shown in Fig. 1, the target cells were
stained with anti-CD45-FITC and analyzed in a two-parameter dot plot
of the first fluorescence channel versus side scatter. Lymphocytes,
monocytes, and granulocytes could be distinguished by the density of
epitope expression and their side scatter characteristics
(20), which allowed each of them to be gated exclusively.
The Flow Count Fluorospheres are polystyrene microparticles and contain
fluorescence dyes with a broad emission spectrum of 510 to 700 nm. They
are easy to detect by using a third fluorescence channel versus forward
scatter diagram. Gate H reveals a tight distribution of all
Fluorosphere singlets. Cell viabilities were assessed by propidium
iodide staining (Sigma, Deisenhofen, Germany). Propidium iodide was
added at a final concentration of 10 µg/ml for 10 min.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 1.
Representative flow cytometric analysis of leukocyte
subpopulations using anti-CD45-FITC staining and fluorescent
microspheres (Flow Count Fluorospheres) for cell quantification.
|
|
HLA class I typing by a lymphocytotoxicity test.
PBMC were
subjected to HLA class I typing by the microcytotoxicity test with
commercial 72-well polystyrene typing trays (Lymphotype AB-72;
Biotest), which were primed with 1-µl volumes of antisera. One
microliter of PBMC, containing about 3 × 103 cells,
was added and incubated for 30 min at 20°C; then 5 µl of freshly
prepared rabbit complement was added, and PBMC were further incubated
for 60 min at 20°C. The staining and fixing procedures were carried
out simultaneously by a softdrop technique using 8 µl of Stain-Fix
(One Lambda, Canoga Park, Calif.). The trays were left at 20°C for at
least 30 min so as to allow the cells to settle completely. Living and
damaged cells were distinguished by visualization on a phase-contrast
microscope. Viable PBMC are characterized by their small size and their
bright and refractile appearance. Cytotoxicity reactions were
quantified as the percentage of complement-damaged cells according to
the scoring system of the IHW. Scores 1 and 2, with 0 to 20% dead
cells, correspond to a negative result, whereas scores 6 through 8 demonstrate strong positive reactions, with 51 to 100% damaged cells,
and score 4 (21 to 50% damaged cells) reflects weak or doubtful
positive reactions.
Statistics.
Means and standard deviations were calculated
for each subject. The median was given as the descriptive statistic for
relative, nonparametrically distributed parameters (viability and
background score). Comparisons between different storage times and
density gradient techniques were tested for statistical significance by using the Friedman test for related variables from the same population. A P value of <0.05 was considered significant.
 |
RESULTS |
The recovery of PBMC and the extent of granulocyte contamination
were assessed by flow cytometric analysis as shown in Fig. 2. The leukocyte subpopulation counts
obtained by using the Ficoll gradient technique (standard) or the CPT
method with two different protocols are compared in Fig.
3A. With 2 h of storage, the mean yield of PBMC by using CPT (protocol A or B) was 77.6% (1.32 × 107 ± 0.61 × 107) of the original
content and significantly higher (P = 0.04) than that
with the standard Ficoll method, where a mean recovery of 64.1%
(1.09 × 107 ± 0.52 × 107) was
seen. The mean recovery decreased to 55.6% (0.94 × 107 ± 0.40 × 107) at 24 h and
further decreased significantly (P = 0.007) to 47.6% (0.81 × 107 ± 0.37 × 107) at
48 h with the standard technique. When CPT protocol A was used, a
depletion of the PBMC over time was also observed. Mean leukocyte
recovery dropped to 58.7% (0.99 × 107 ± 0.44 × 107) and significantly to 31.2% (0.53 × 107 ± 0.28 × 107) after 24 and 48 h, respectively (P
0.001). However, when CPT protocol B was used, 71.2% (1.21 × 107 ± 0.51 × 107) of the total cells were isolated at 24 h,
which was slightly lower than the original value. In contrast, CPT
protocol B was totally ineffective for isolating PBMC after 48 h
of storage due to the fact that the erythrocytes did not pass the gel
barrier of the CPT. In comparison to the standard Ficoll technique,
both of the CPT protocols produced significantly higher yields of PBMC after 24 h of storage (P
0.001).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 2.
Flow cytometric analysis of leukocyte differential using
anti-CD45-FITC versus side-angle light scatter. The recovery of
mononuclear cells and the granulocyte contamination are determined in a
representative sample. The standard gradient technique is compared with
the Ficoll-prefilled tubes (CPT protocols A and B) at different storage
times.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
Determination of cell recovery and granulocyte
contamination after the isolation of mononuclear cells by using
different gradient techniques and storage times.
|
|
The impurity of the PBMC was assessed by measuring the level of
contamination by granulocytes (Fig. 3B). When PBMC isolation was
performed 2 h after blood collection, no difference was observed between the standard method and the CPT method, with granulocyte contaminations of 0.6% (1.4 × 105 ± 0.5 × 105) and 1.2% (2.7 × 105 ± 1.5 × 105), respectively. With the standard technique the extent
of contamination was significantly higher (P
0.001)
at 16.0% (3.7 × 106 ± 2.2 × 106)
after 24 h and 19.8% (4.9 × 106 ± 2.4 × 106) after 48 h. In contrast, when the CPT method was
used, the purity of the PBMC always remained stable, and a maximum of
2.0% (4.6 × 105 ± 1.5 × 105)
granulocytes was observed (P
0.001).
In general, viabilities decreased when the storage time was prolonged,
and B lymphocytes were more vulnerable than T lymphocytes (Fig.
4). For the three storage times, median
amounts of nonviable T and B lymphocytes with the standard Ficoll
technique were 1.0, 1.9, and 4.0% and 3.6, 9.9, and 17.0%,
respectively. The differences between the values after 2 and 48 h
were significant for both cell types (P
0.001). When
CPT protocol A was used, a significant increase (P
0.001) in dead cells over time was also observed, with medians of
1.7, 4.0, and 15.4% for T lymphocytes and 8.9, 12.5, and 24.0% for B
lymphocytes. In contrast with these findings, a lower percentage of
damaged cells was observed with CPT protocol B. Dead T lymphocytes
amounted to 1.7 and 3.3%, and dead B lymphocytes amounted to 8.9 and
8.6%, after 2 and 24 h of storage, respectively, whereas after
48 h, whole blood could not be processed. A comparison of
lymphocyte viabilities revealed that with the standard method, 1.0% of
the T lymphocytes and 3.6% of the B lymphocytes were dead after 2 h of storage. Values for the CPT method, however, were significantly
higher at 1.7% (P
0.001) and 8.9% (P = 0.002), respectively. After 24 h, the median of 1.9% dead T
lymphocytes obtained by using the standard protocol was also
significantly lower (P
0.001) than that obtained
with CPT protocol A or B (4.0 or 3.3%). With the B lymphocytes,
however, none of the viabilities were found to be significantly
different from the others. Medians were 9.9, 12.5, and 8.6% with the
standard protocol, CPT protocol A, and CPT protocol B, respectively.
After 48 h of storage, cell deaths for both T and B lymphocytes
were significantly lower (P
0.001) with the standard
procedure (4.0 and 17.0%) than they were with CPT protocol A (15.4 and
24.0%).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Determination of cell viability by using propidium
iodide (PI) staining. Three density gradient techniques and three
storage times are compared.
|
|
After storage for the shortest period of time, HLA typing could be
accurately performed. HLA typing with lymphocytes isolated after
24 h of storage revealed a lower median background with CPT
protocol B (score 1) than with CPT protocol A (score 2) or the standard
Ficoll technique (score 2). After 48 h the background scores
increased to 6 (standard technique) and 8 (CPT protocol A), and it was
thus impossible to perform proper HLA typing by using any of these protocols.
 |
DISCUSSION |
For serological HLA class I typing and the detection of specific
HLA antibodies, the complement-mediated microcytotoxicity technique
first described by Terasaki and McClelland (18) is still the
standard procedure and the basic diagnostic tool for decision making in
donor-recipient matching. In order to avoid HLA typing errors, it is of
major importance to obtain pure and viable mononuclear cells. Several
factors can affect background scores and the strength of cytotoxicity
reactions, whereby in a worst-case scenario misinterpretations can
occur. These include insufficient standardization of the cell
preparation procedure due to storage or transport conditions (6,
8, 13, 22), patient health and treatment status, the quantity of
cells, and the quality of cadaveric organ donors. Because specialized
HLA typing laboratories are often requested to perform such tests by
peripheral authorities, the storage and transportation conditions for
both whole-blood samples and PBMC suspensions were also assessed.
The recovery of PBMC by the novel CPT method was significantly superior
to recovery by the standard Ficoll technique after 2 and 24 h of
storage (P
0.001). This result reflects the
necessary restrictions made upon the manual pipetting of PBMC from the
interface. A sufficient yield prior to HLA typing is important for
patients with hematological malignancies or immunosuppressive
treatment, so that low absolute lymphocyte counts may be apparent. With
CPT protocol B, sufficient recoveries of PBMC were achieved until 24 h of storage, whereas after 48 h, erythrocyte clumping
completely impaired PBMC isolation, since the cells could not pass
through the gel barrier. In contrast, with CPT protocol A, the isolated PBMC were resuspended in autologous plasma after centrifugation. The
recovery rates fell to 58.7 and 31.2% after 24 and 48 h of storage, which might be caused by cell sedimentation on the top of the
gel barrier or by early contact with the Ficoll solution and incomplete removal.
The purity of the PBMC was equal to or greater than 98% in all
analyses using the CPT technique regardless of the time of storage.
With fresh blood samples, the PBMC isolated by the conventional density
gradient technique were more than 99% pure. In contrast, this purity
progressively decreased to 80% after 48 h of storage. This was
mainly caused by a strong increase in granulocyte contamination, which
influenced the HLA typing quality. The differences observed with the
CPT method were always found to be significant (P
0.001). Granulocytes were also shown to be present by Dzik
(7), even when cells were stored for 12 h before Ficoll
centrifugation, but the reasons for this remain unknown. The
granulocytes' integrity or density may have become altered, and they
may have aggregated with or even become engulfed by the PBMC.
The viability results obtained by propidium iodide staining did not
correlate well with those obtained by cytotoxicity testing, indicating
that a partial loss of cell integrity may start to disturb HLA typing.
In general, regardless of the density gradient technique, the
percentage of dead B lymphocytes was always higher than that of dead T
lymphocytes. With all protocols used, a more marked reduction in median
viability was observed after 48 h of storage, and as such the
isolated PBMC were not suitable for cytotoxicity testing. With either
CPT or Ficoll centrifugation after both 2 and 24 h, the measured
changes in cell viability were acceptable, although the standard
procedure resulted in significantly more viable T lymphocytes
(P
0.001). This beneficial effect was probably caused by the washing steps performed in the traditional procedure immediately after Ficoll centrifugation, whereas with CPT protocol A,
all cells, including dead ones, were retained in the original CPT after
exposure to the Ficoll solution. In our hands both cell separation
techniques were shown to be sufficient for HLA typing, but sample
storage and transportation time was limited to 24 h with respect
to cell viability. The CPT technique enriches pure and viable PBMC,
which allows for sensitive and specific HLA ABC typing with a low level
of background staining. These results are comparable to those obtained
by immunomagnetic HLA typing techniques, and the CPT technique might
partly replace the requirement for immunomagnetic techniques
(21). In conclusion, the novel, ready-to-use isolation
procedure using Vacutainer CPT offers the opportunity to isolate pure
and viable PBMC. The procedure is easier to perform and is much less
time-consuming than the conventional technique. Furthermore, the CPT
method is more standardized and resulted in a higher PBMC yield without
any relevant contamination by granulocytes. It was advantageous with
regard to cell recovery and viability to store blood samples in CPT for
24 h before centrifugation. Both methods are able to support
sufficient cell viability for at least 24 h of storage or
transportation, which would permit their use in serological HLA typing
and HLA antibody detection or various other applications.
 |
ACKNOWLEDGMENTS |
We gratefully acknowledge Martin Saballus for technical
assistance and Una Doherty for editing the manuscript.
We acknowledge the financial support of Becton Dickinson Vacutainer
Systems and the technical supervision of Rita Bergendahl.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Luebeck, Institute of Immunology and Transfusion Medicine, Ratzeburger Allee 160, 23538 Luebeck, Germany. Phone: 49-451-5002841. Fax: 49-451-5002857. E-mail: schlenke{at}immu.mu-luebeck.de.
 |
REFERENCES |
| 1.
|
Ashmore, L. M.,
G. M. Shopp, and B. S. Edwards.
1989.
Lymphocyte subset analysis by flow cytometry. Comparison of three different staining techniques and effects of blood storage.
J. Immunol. Methods
118:209-215[Medline].
|
| 2.
|
Bein, G.,
R. Gläser, and H. Kirchner.
1992.
Rapid HLA-DRB1 genotyping by nested PCR amplification.
Tissue Antigens
39:68-73[Medline].
|
| 3.
|
Blasczyk, R.,
U. Hahn,
J. Wehling,
D. Huhn, and A. Salama.
1995.
Complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single-strand conformation polymorphism analysis.
Tissue Antigens
46:86-95[Medline].
|
| 4.
|
Böyum, A.
1968.
Separation of leukocytes from blood and bone marrow.
Scand. J. Clin. Lab. Investig.
21:77-89[Medline].
|
| 5.
|
Böyum, A.
1974.
Separation of blood leukocytes, granulocytes and lymphocytes.
Tissue Antigens
4:269[Medline].
|
| 6.
|
De Paoli, P.,
D. Villalta,
S. Battistin,
A. Gasparollo, and G. Santini.
1983.
Selective loss of OKT8 lymphocytes on density gradient centrifugation separation of blood mononuclear cells.
J. Immunol. Methods
61:259-260[Medline].
|
| 7.
|
Dzik, W. H.
1983.
Granulocytes contaminate Ficoll preparations of stored blood.
Transfusion
23:538-539[Medline].
|
| 8.
|
Dzik, W. H., and L. Neckers.
1984.
Mononuclear cell-surface antigens during storage of banked blood.
Transplantation
38:67-71[Medline].
|
| 9.
|
Mansour, I.,
P. Bourin,
P. Rouger, and C. Doinel.
1990.
A rapid technique for lymphocyte preparation prior to two-color immunofluorescence analysis of lymphocyte subsets using flow cytometry.
J. Immunol. Methods
127:61-70[Medline].
|
| 10.
|
Mullis, K. B., and F. A. Faloona.
1987.
Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.
Methods Enzymol.
155:335-350[Medline].
|
| 11.
|
Olerup, O., and H. Zetterquist.
1992.
HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.
Tissue Antigens
39:225-235[Medline].
|
| 12.
|
Pelegrí, C.,
M. P. Rodríguez-Palmero,
M. Morante,
J. Comas,
J. C. M. Castell, and A. Franch.
1995.
Comparison of four lymphocyte isolation methods applied to rodent T cell subpopulations and B cells.
J. Immunol. Methods
187:265-271[Medline].
|
| 13.
|
Prince, H. E., and I. Arens.
1986.
Effect of storage on lymphocyte surface markers in whole blood units.
Transplantation
41:235-238[Medline].
|
| 14.
|
Saiki, R. K.,
T. L. Bugawan,
G. T. Horn,
K. B. Mullis, and H. A. Erlich.
1986.
Analysis of enzymatically amplified -globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.
Nature
324:163-166[Medline].
|
| 15.
| Schlenke, P., C. Frohn, H. Klüter, M. Saballus,
H. J. Hammers, S. R. Zajac, and H. Kirchner. Evaluation
of a flow cytometric method for simultaneous leukocyte phenotyping and
quantification by fluorescent microparticles. Cytometry, in press.
|
| 16.
|
Tamul, K. R.,
R. G. O'Gorman,
M. Donovan,
J. L. Schmitz, and J. D. Folds.
1994.
Comparison of a lysed whole blood method to purified cell preparations for lymphocyte immunophenotyping: differences between healthy controls and HIV-positive specimens.
J. Immunol. Methods
167:237-243[Medline].
|
| 17.
|
Tamul, K. R.,
J. L. Schmitz,
K. Kane, and J. D. Folds.
1995.
Comparison of the effects of Ficoll-Hypaque separation and whole blood lysis on results of immunophenotypic analysis of blood and bone marrow samples from patients with hematologic malignancies.
Clin. Diagn. Lab. Immunol.
2:337[Abstract].
|
| 18.
|
Terasaki, P. I., and J. D. McClelland.
1964.
Microdroplet assay of human serum cytotoxins.
Nature
204:998-1000[Medline].
|
| 19.
|
Terstappen, L. W. M. M.,
H. Meiners, and M. R. Loken.
1989.
A rapid sample preparation technique for flow cytometric analysis of immunofluorescence allowing absolute enumeration of cell subpopulations.
J. Immunol. Methods
123:103-112[Medline].
|
| 20.
|
Terstappen, L. W.,
Z. Hollander,
H. Meiners, and M. R. Loken.
1990.
Quantitative comparison of myeloid antigen on five lineages of mature peripheral blood cells.
J. Leukoc. Biol.
48:138-148[Abstract].
|
| 21.
|
Vartdal, F.,
G. Gaudernach,
S. Funderud,
A. Bratlie,
T. Lea,
J. Ugelstad, and E. Thorsby.
1986.
HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation a fast and reliable technique.
Tissue Antigens
28:301-312[Medline].
|
| 22.
|
Weiblen, B. J.,
K. Debell, and C. R. Valeri.
1983.
"Acquired immunodeficiency" of blood stored overnight.
N. Engl. J. Med.
309:793[Medline].
|
Clinical and Diagnostic Laboratory Immunology, November 1998, p. 808-813, Vol. 5, No. 6
1071-412X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.